HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $448,572 | +2.5% | 435,507 | +15.4% | 0.00% | – |
| Q2 2023 | $437,632 | -36.4% | 377,270 | -17.3% | 0.00% | – |
| Q1 2023 | $688,555 | -66.1% | 455,997 | -43.8% | 0.00% | – |
| Q4 2022 | $2,029,754 | -49.2% | 811,901 | -14.2% | 0.00% | -100.0% |
| Q3 2022 | $3,994,000 | -29.7% | 946,313 | -53.6% | 0.00% | 0.0% |
| Q2 2022 | $5,685,000 | -32.4% | 2,037,895 | +38.6% | 0.00% | 0.0% |
| Q1 2022 | $8,412,000 | +215.4% | 1,470,828 | +403.4% | 0.00% | – |
| Q4 2021 | $2,667,000 | -31.6% | 292,199 | -19.9% | 0.00% | -100.0% |
| Q3 2021 | $3,899,000 | -51.7% | 364,769 | -29.9% | 0.00% | 0.0% |
| Q2 2021 | $8,077,000 | -19.5% | 520,398 | -15.9% | 0.00% | 0.0% |
| Q1 2021 | $10,030,000 | +3.1% | 618,728 | +34.6% | 0.00% | -50.0% |
| Q4 2020 | $9,731,000 | +249.7% | 459,763 | +144.7% | 0.00% | +100.0% |
| Q3 2020 | $2,783,000 | +106.3% | 187,884 | +104.7% | 0.00% | – |
| Q2 2020 | $1,349,000 | -78.0% | 91,795 | -82.4% | 0.00% | -100.0% |
| Q1 2020 | $6,118,000 | +33.2% | 521,181 | +166.7% | 0.00% | +100.0% |
| Q4 2019 | $4,592,000 | +265.3% | 195,423 | +187.7% | 0.00% | – |
| Q3 2019 | $1,257,000 | +78.3% | 67,915 | +79.0% | 0.00% | – |
| Q2 2019 | $705,000 | -55.1% | 37,938 | -40.9% | 0.00% | – |
| Q1 2019 | $1,571,000 | -85.9% | 64,246 | -85.1% | 0.00% | -100.0% |
| Q4 2018 | $11,149,000 | +110.2% | 429,777 | +156.4% | 0.00% | +200.0% |
| Q3 2018 | $5,305,000 | -62.5% | 167,606 | -54.0% | 0.00% | -75.0% |
| Q2 2018 | $14,142,000 | +241.3% | 364,002 | +142.4% | 0.00% | +300.0% |
| Q1 2018 | $4,144,000 | +65.1% | 150,140 | +8.3% | 0.00% | 0.0% |
| Q4 2017 | $2,510,000 | +115.8% | 138,676 | +92.5% | 0.00% | – |
| Q3 2017 | $1,163,000 | -16.9% | 72,043 | -28.7% | 0.00% | – |
| Q2 2017 | $1,400,000 | -53.4% | 101,073 | -49.5% | 0.00% | – |
| Q1 2017 | $3,002,000 | -26.9% | 200,066 | -36.2% | 0.00% | -100.0% |
| Q4 2016 | $4,108,000 | +183.7% | 313,746 | +273.4% | 0.00% | – |
| Q3 2016 | $1,448,000 | +252.3% | 84,014 | +268.4% | 0.00% | – |
| Q2 2016 | $411,000 | +134.9% | 22,804 | +146.3% | 0.00% | – |
| Q1 2016 | $175,000 | -87.4% | 9,258 | -82.3% | 0.00% | -100.0% |
| Q4 2015 | $1,393,000 | -27.3% | 52,173 | -33.5% | 0.00% | 0.0% |
| Q3 2015 | $1,915,000 | -73.2% | 78,497 | -65.7% | 0.00% | -50.0% |
| Q2 2015 | $7,135,000 | +69.8% | 228,962 | -20.7% | 0.00% | 0.0% |
| Q1 2015 | $4,203,000 | +1836.9% | 288,802 | +1236.4% | 0.00% | – |
| Q4 2014 | $217,000 | +578.1% | 21,610 | +478.1% | 0.00% | – |
| Q3 2014 | $32,000 | -61.9% | 3,738 | -45.4% | 0.00% | – |
| Q2 2014 | $84,000 | -94.8% | 6,845 | -94.1% | 0.00% | -100.0% |
| Q1 2014 | $1,624,000 | – | 116,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |